Summary
Castle Biosciences Incorporated (Castle Biosciences) is a diagnostic company which develops and commercializes diagnostic and prognostic tests for cancers. It develops and manufactures molecular diagnostic assays. Its tests include decisionDX-melanoma, decisionDX-EC, decisionDX-UM, decision DX-thymoma, decisionDX-G-CIMP and decisionDX-GBM. Castle Biosciences’ DecisionDx-EC test is used to predict chance of response to preoperative chemoradiation therapy in individual patients with esophageal cancer. It provides tests for cutaneous melanoma, uveal melanoma, esophageal cancer, mesothelioma, glioblastoma multiforme and assays in development for rectal cancer. The company’s partner’s portfolio includes Mountain Group Capital and Affiliates, HealthQuest Capital and Industry Ventures among others. It has its operations in Canada, Latin America, Europe, Israel, and Australia. Castle Biosciences is headquartered in Friendswood, Texas, the US.
Castle Biosciences Incorporated - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Castle Biosciences Incorporated, Medical Equipment, Deals By Year, 2010 to YTD 2016 5
Castle Biosciences Incorporated, Medical Equipment Deals By Type, 2010 to YTD 2016 7
Castle Biosciences Incorporated, Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Castle Biosciences Incorporated, Medical Equipment, Deals By Market, 2010 to YTD 2016 9
Castle Biosciences Incorporated, Medical Equipment, Deals Summary, 2010 to YTD 2016 10
Castle Biosciences Incorporated, Medical Equipment, Deal Details 11
Venture Financing 11
Castle Biosciences Raises USD11.7 Million in First Tranche of Series F Financing 11
Castle Biosciences Secures USD6 Million from Silicon Valley Bank 12
Castle Biosciences Raises USD11.8 Million in Series E Venture Financing 13
Castle Biosciences Raises US$1 Million In Venture Financing 14
Castle Biosciences Raises US$1 Million In Venture Financing 15
Castle Biosciences Raises USD1.5 Million in Venture Financing 16
Castle Biosciences Raises US$1 Million In Venture Financing 17
Partnerships 18
Castle Biosciences Enters Into Licensing Agreement With Brigham and Women's Hospital For Mesothelioma Test 18
Castle Biosciences Enters Into Licensing Agreement With Indiana University Research & Technology 19
Castle Biosciences Enters Into Licensing Agreement With Washington University 20
Castle Biosciences Incorporated - Key Competitors 21
Key Employees 22
Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Corporate Communications 24
Jun 29, 2015: Castle Biosciences Announces the Appointment of Veracyte CEO Bonnie H. Anderson to its Board of Directors 24
May 28, 2015: Castle Biosciences Expands Sales Force and Appoints Patrick Hall as Executive Director of Medical Affairs, Promotes Robert W. Cook to Executive Director, R&D 25
Apr 21, 2015: Castle Biosciences Hires Vice President of Marketing 26
Feb 24, 2015: Castle Biosciences Announces New Director Appointment and CFO Hire 27
Product News 28
Apr 02, 2015: New Gene Expression Profile Test Used in Combination with Sentinel Lymph Node Biopsy Improves Prediction of Metastasis and Death in Patients with Head and Neck Melanoma 28
Mar 20, 2015: Study Demonstrates New Noninvasive Gene Expression Profile Test Predicts Melanoma Risk More Accurately Than AJCC Online Predictor Tool 30
Feb 23, 2015: Study of Castle Biosciences Multi-Analyte Test for Esophageal Cancer Published in Gastrointestinal Cancer: Targets and Therapy 31
Jan 06, 2015: Study of Castle Biosciences’ Skin Melanoma Gene Test Published in Clinical Cancer Research 32
Clinical Trials 33
Apr 02, 2015: New Gene Expression Profile Test Used in Combination with Sentinel Lymph Node Biopsy Improves Prediction of Metastasis and Death in Patients with Head and Neck Melanoma 33
Other Significant Developments 35
Apr 14, 2015: Castle Biosciences Secures $6 Million Credit Facility from Silicon Valley Bank 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
List of Tables
Castle Biosciences Incorporated, Medical Equipment, Key Facts 1
Castle Biosciences Incorporated, Medical Equipment, Deals Summary, 2010 to YTD 2016 1
Castle Biosciences Incorporated, Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Castle Biosciences Incorporated, Medical Equipment Deals By Type, 2010 to YTD 2016 7
Castle Biosciences Incorporated, Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Castle Biosciences Incorporated, Deals By Market, 2010 to YTD 2016 9
Castle Biosciences Incorporated, Medical Equipment, Deals Summary, 2010 to YTD 2016 10
Castle Biosciences Raises USD11.7 Million in First Tranche of Series F Financing 11
Castle Biosciences Secures USD6 Million from Silicon Valley Bank 12
Castle Biosciences Raises USD11.8 Million in Series E Venture Financing 13
Castle Biosciences Raises US$1 Million In Venture Financing 14
Castle Biosciences Raises US$1 Million In Venture Financing 15
Castle Biosciences Raises USD1.5 Million in Venture Financing 16
Castle Biosciences Raises US$1 Million In Venture Financing 17
Castle Biosciences Enters Into Licensing Agreement With Brigham and Women's Hospital For Mesothelioma Test 18
Castle Biosciences Enters Into Licensing Agreement With Indiana University Research & Technology 19
Castle Biosciences Enters Into Licensing Agreement With Washington University 20
Castle Biosciences Incorporated, Key Competitors 21
Castle Biosciences Incorporated, Key Employees 22
Castle Biosciences Incorporated, Other Locations 23
List of Figures
Castle Biosciences Incorporated, Medical Equipment, Deals by Type, 2010 to YTD 2016 1
Castle Biosciences Incorporated, Medical Equipment, Deals By Year, 2010 to YTD 2016 1
Castle Biosciences Incorporated, Medical Equipment, Deals By Region, 2010 to YTD 2016 1
Castle Biosciences Incorporated, Medical Equipment, Deals By Market, 2010 to YTD 2016 1
Castle Biosciences Incorporated, Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Castle Biosciences Incorporated, Medical Equipment, Deals by Type, 2010 to YTD 2016 7
Castle Biosciences Incorporated, Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Castle Biosciences Incorporated, Medical Equipment, Deals by Market, 2010 to YTD 2016 9
